Clinical trial
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
NCT02356835 is registered in ClinicalTrials.gov with Origin Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
- Lead sponsor
- Origin Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- March 31, 2016
- Enrollment
- 10 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
foot ulcer, diabetic